Latest Share Chat

IN BRIEF: Open Orphan non-exec Mo Khan switches to chief executive

Thu, 24th Feb 2022 14:48

Open Orphan PLC - London-based pharmaceutical services - Moves Non-Executive Director Mo Khan to chief executive officer, effective immediately. Khan had joined the Open Orphan board back in October. The company notes he has 25 years of clinical research experience. Cathal Friel remains executive chair, while Open Orphan will aim to find a new independent non-executive director within the next six months.

Current stock price: 13.53 pence, down 9.8% on Thursday

12-month change: down 50%

By Tom Waite; thomaslwaite@alliancenews.com

Related Shares

More News

18 Oct 2022 22:04

TRADING UPDATES: essensys loss widens; Carclo demand strong

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

15 Sep 2022 13:02

IN BRIEF: Open Orphan denies any involvement in insider trading claim

Open Orphan PLC - London-based research organisation testing infectious and respiratory disease products - Confirms that it is helping the relevant Ir...

8 Sep 2022 20:43

EARNINGS SUMMARY: Open Orphan name change; Secured Income winds down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

1 Sep 2022 21:55

TRADING UPDATES: Kropz gets more cash; Audioboom releases new podcasts